Analysis of Molecular Mechanism of ARF-dependent apoptotic cell death
Analysis of Molecular Mechanism of ARF-dependent apoptotic cell death
批准号:
13214040
负责人:
KAMIJO Takehiko
金额:
$21.76万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The tumor suppressor p19ARF, p14ARF in humans, is encoded by the Ink4a/ARF locus (Quelle, D. E.et al., (1995) Cell 83, 993-100) and mutated, deleted, or silenced in many forms of cancer. pl9ARF induces growth arrest by antagonizing the activity of the p53-negative regulator, Mdm2, thereby permitting a p53 transcriptional response (Kamijo, T. et al., (1997) Cell 91, 649-659; Kamijo T. et al., (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8292-829'). Although ARF activation and p53 stabilization alone are not sufficient to induce apoptosis in all cell types, upregulation ofp53 in this way strongly sensitizes cells to die in response to genotoxic stresses or additional apoptotic signals induced by oncogenes themselves. In this project, we first analyzed the mechanism of ARF-dependent apoptosis and demonstrated that ARF induces mitochondria-dependent apoptosis in p53 wild-type, ARF/p16-null cells. We also found that ARF evokes cytocbrome c release from mitochondria, decreases mitochondria mem … More brane potential and activates pro-caspase-9 to induce apoptosis. Our findings suggest that this apoptotic cellular modulation is brought about by up-regulation of the pro-apoptotic Bc1-2 family proteins Bax and Bim, and down-regulation of anti apopt3tic Bcl-2, in mitochondrial fractions. Additionally, ARF seems to down-tegulate Bc1-2 in a p53-dependent manner, while up-regulating Bax/Bim via a p53-independent pathway (Nakazawa Y, Kamuo, Koike K, Noda T. J Biol Chem. 278(30) : 27888-95. 2003)A recent study showed that triple knockout (TKO) mice lacking ARF, p53, and MDM2 develop multiple and more aggressive tumors per animal than mice lacking either gene alone (Weber, J. D et al., (1999) Nat. Cell Biol. 1, 20-26), indicating that ARF may suppress tumor progression by a p53/MDM2-independent manner. Moreover, previous reports presented that murine and human ARFs interact with MDM2 via NH2-terminal domains, but the functional domain of ARF and the molecular mechanism of p53/MDM2-independent tumor suppression has thus far not been identified. Taken together these findings, we next addressed the molecular mechanism of ARF-induced apoptotic cell death in a p53-independent manner using a p53/Rb-inactivated cell line, and, surprisingly, found that the COOH-terminal of ARF has the ability to induce p53-independent cell death. This is the first report that describes the apoptotic cell death-function of the p19ARF COOH-terminal. Furthermore, we address the responsible caspase cascade for p19ARF COOH-terminal induced apoptosis and relationship between the activated caspases and MAPKs controlling p19ARF COOH-terminal-induced apoptosis. For further investigation of ARF-induced cell death, we made p53/Rb-inactivated cells by introducing SV4OT into ARF-null MEFs. Re-introduction of ARF into the p53/Rb-inactivated cells up-regulated mitochondria-dependent apoptotic cell death accompanied cytochrome c release from mitochondria and activation of the intrinsic pathway caspases, i.e. caspase-9,-3 and-7. Interestingly, ARF bound SV4OT in the ARF-induced cells and re-activation of p53 was seemed to be mediated by the SV4OT inactivation by ARF, resulting in the mitochondrial dysfunction (Nakazawa Y and Kamijo T, submitted). Less
期刊论文(82)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Successful unrelated cord blood transplantation using a reduced-intensity conditioning regimen in a 6・month・old infant with congenital neutropenia complicatod by severe pneumonia.
对一名患有先天性中性粒细胞减少症并发严重肺炎的 6 个月大婴儿,使用降低强度调理方案成功进行无关脐带血移植。
DOI:
--
发表时间:
2004
期刊:
Int J Hematol. 80(3)
影响因子:
--
作者:
[Nakazawa Y, Sakashita K, Kinoshita M, Saida K, Shigemura T, Yanagisawa R, Shikama N, Kamijo T, Koike K.]
通讯作者:
Koike K.
ST1571 inhibits growth and adhesion of human mast cells in culture.
ST1571 抑制培养物中人类肥大细胞的生长和粘附。
DOI:
--
发表时间:
2003
期刊:
J Leukoc Biol. 74
影响因子:
--
作者:
[Takeuchi K, Koike K, Kamijo T, 他10名]
通讯作者:
他10名
STI571 inhibits growth and adhesion of human mast cells in culture
STI571 抑制培养物中人类肥大细胞的生长和粘附
DOI:
10.1189/jlb.0602284
发表时间:
2003
期刊:
Journal of Leukocyte Biology
影响因子:
5.5
作者:
[K. Takeuchi, K. Koike, T. Kamijo, S. Ishida, Y. Nakazawa, Y. Kurokawa, K. Sakashita, T. Kinoshita, Shigeyuki Matsuzawa, M. Shiohara, T. Yamashita, M. Nakajima, A. Komiyama]
通讯作者:
A. Komiyama
ARF tumor dependent apoptosis by modulation of mitochondrial Bcl
通过调节线粒体 Bcl 来实现 ARF 肿瘤依赖性细胞凋亡
DOI:
--
发表时间:
2003
期刊:
J Biol Chem. 278
影响因子:
--
作者:
[Nakazawa Y, Kamijo T, Koike K.Noda T.]
通讯作者:
Koike K.Noda T.
Hagimoto R: "A possible role for maternal HLA antibodyin a case of alloimmune neonatal neutropenia"Transfusion. 41. 615-620 (2001)
Hagimoto R:“母体 HLA 抗体在同种免疫新生儿中性粒细胞减少症中的可能作用”输血。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 35 条
Development of cancer stem cell-targeted therapy by study of tumor sphere formation mechanism using comprehensive and genetic approach
-
批准号:24390269
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2012
-
负责人:KAMIJO Takehiko
-
依托单位:
Screening of polycomb Bmi1 targets for development of Cancer Stem Cell-targeted therapy for neuroblastoma
-
批准号:21591377
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:KAMIJO Takehiko
-
依托单位:
Investigation of new molecular target of neuroblastoma therapy: The role of p53 pathway in neuroblastoma cell death
-
批准号:17591077
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2005
-
负责人:KAMIJO Takehiko
-
依托单位:
Investigation of a new molecular target-based treatment of caneer-drug resistant pediatric solid tumors
-
批准号:15591098
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:KAMIJO Takehiko
-
依托单位:
Analysis of the mechanism for suppression of childhood leukemia via ARF-p53 pathway
-
批准号:12670736
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:KAMIJO Takehiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
-
批准号:2026JJ81586
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈燕华
-
依托单位:
基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
-
批准号:2026JJ82384
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:颜志鹏
-
依托单位:
APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
-
批准号:JCZRQNB202600696
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究
-
批准号:JCZRLH202601033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
白藜芦醇通过SIRT1/p53乙酰化调控铁死亡及其在口腔鳞状细胞癌顺铂增敏中的作用研究
-
批准号:2026JJ80394
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:毛琛
-
依托单位:
中性粒细胞弹性蛋白酶抑制剂Sivelestat通过CCN2/P53/BNIP3通路改善阿霉素心脏毒性线粒体自噬的分子机制研究
-
批准号:2026JJ30190
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李小平
-
依托单位:
基于“心理应激”从P53/AMPK通路介导线粒体能量代谢研究疏肝健脾解毒方对肝郁型三阴乳腺癌铁死亡作用机制
-
批准号:2026JJ50614
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李琳霈
-
依托单位:
基于miR-218-5p/NDRG4/p53通路研究“阴中隐阳”手法针刺风池 穴治疗青光眼性视神经损伤的作用机制
-
批准号:JCZRLH202600426
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
GINS1通过调控肿瘤干性及PTP4A1/p53信号轴促进非小细胞肺癌发生发展及靶向干预研究
-
批准号:JCZRLH202600663
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
软饮食下Igfbp5调控p53/p21通路诱导颞下颌关节退行性变的机制研究
-
批准号:2026JJ60602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周典
-
依托单位: